Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in PFE — Pfizer Inc

CIK 886982 NEW YORK, NY
Back to PFE Full portfolio

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,276,043,746
-$46,680,264 QoQ
Shares Held
52,991,850
+12.5% QoQ
Ownership
0.930%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#13
of 2,816 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Jun 30, 2026
CallValue
$16,937,872
CallShares
703,400
PutValue
$27,400,632
PutShares
1,137,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $29,799,350,964 across 16 Drug Manufacturers - General names. PFE ranks #8 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 7,652,960 $9,179,190,573
2 JNJ
Johnson & Johnson
 19,722,544 $5,008,934,496
3 ABBV
AbbVie Inc.
 16,291,630 $4,099,625,769
4 MRK
Merck & Co., Inc.
 22,075,139 $2,836,655,359
5 AZN
Astrazeneca PLC
 9,742,396 $1,847,353,128
6 AMGN
Amgen Inc
 4,130,732 $1,495,820,670
7 GILD
Gilead Sciences, Inc.
 10,778,294 $1,361,729,661
8 PFE
Pfizer Inc
This page 		52,991,850 $1,276,043,746

All Filings in PFE

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,937,872 703,400
2026-06-30 $27,400,632 1,137,900
2026-06-30 $1,276,043,746 52,991,850
2026-03-31 $17,095,104 608,800
2026-03-31 $1,322,724,010 47,105,556
2026-03-31 $58,850,064 2,095,800
2025-12-31 $30,876,000 1,240,000
2025-12-31 $5,976,000 240,000
2025-12-31 $997,383,491 40,055,562
2025-09-30 $836,137,358 32,815,438
2025-09-30 $14,989,884 588,300
2025-09-30 $23,951,200 940,000
2025-06-30 $28,707,432 1,184,300
2025-06-30 $3,636,000 150,000
2025-06-30 $735,487,993 30,341,914
2025-03-31 $6,335,000 250,000
2025-03-31 $647,491,656 25,552,157
2025-03-31 $16,579,962 654,300
2024-12-31 $11,301,780 426,000
2024-12-31 $8,762,859 330,300
2024-12-31 $459,466,886 17,318,767
2024-09-30 $747,422,322 25,826,618
2024-09-30 $14,898,312 514,800
2024-09-30 $24,150,430 834,500
2024-06-30 $14,795,824 528,800
2024-06-30 $11,317,910 404,500
2024-06-30 $976,970,355 34,916,739
2024-03-31 $13,500,375 486,500
2024-03-31 $620,133,521 22,347,154
2024-03-31 $14,332,875 516,500
2023-12-31 $20,533,028 713,200
2023-12-31 $692,958,773 24,069,426
2023-12-31 $41,592,913 1,444,700
2023-09-30 $815,358,170 24,581,193
2023-09-30 $58,982,894 1,778,200
2023-09-30 $22,495,894 678,200
2023-06-30 $25,041,436 682,700
2023-06-30 $961,345,898 26,208,994
2023-06-30 $29,626,436 807,700
2023-03-31 $29,608,560 725,700
2023-03-31 $28,588,560 700,700
2023-03-31 $971,508,504 23,811,483
2022-12-31 $70,132,188 1,368,700
2022-12-31 $95,039,952 1,854,800
2022-12-31 $1,280,155,716 24,983,523
2022-09-30 $64,821,688 1,481,300
2022-09-30 $959,636,230 21,929,530
2022-09-30 $85,458,904 1,952,900
2022-06-30 $81,376,603 1,552,100
2022-06-30 $101,425,835 1,934,500

Report a Problem

Category
Description
Email (optional, for follow-up)